Create Account | Sign In: Author or Forum

 
News  |  Journals  |  Conferences  |  Opinion  |  Articles  |  Forums  |  Twitter    
 
Category: Infections | AIDS | Internal Medicine | Nursing | Pharmacy | Journal

Back to Journal Articles

cART Ups Life Expectancy in Ugandan HIV Patients

Last Updated: July 19, 2011.

 

Ugandan women receiving combo antiretroviral therapy have lower mortality rate than men

Share |

Comments: (0)

Tell-a-Friend

 

  Related
 
Combination antiretroviral therapy may substantially improve life expectancy in patients with HIV in Uganda, with women having a greater life expectancy then men, according to a study published online July 18 in the Annals of Internal Medicine.

TUESDAY, July 19 (HealthDay News) -- Combination antiretroviral therapy (cART) may substantially improve life expectancy in patients with HIV in Uganda, with women having a greater life expectancy then men, according to a study published online July 18 in the Annals of Internal Medicine.

Edward J. Mills, Ph.D., from the University of Ottawa, and colleagues estimated the life expectancy of 22,315 eligible Ugandan patients with HIV after the initiation of cART between 2000 and 2009. All-cause mortality rates and estimated life expectancies were stratified by gender and baseline CD4 cell-count status. The average number of additional years that patients lived after receiving cART was assessed within varying age categories. A total of 1,943 participants were lost to follow-up, and were considered to have died.

The investigators found that, after adjusting for loss to follow-up, the crude mortality rates (deaths per 1,000 person-years) in men and women were 43.9 and 26.9, respectively. A baseline CD4 cell-count status of less than 0.050 × 109 cells/L was correlated with a mortality rate of 67.3 deaths per 1,000 person years, and baseline CD4 cell-count greater than or equal to 0.250 × 10 9 cells/L was correlated with a mortality rate of 19.1 deaths per 1,000 person-years. Life expectancy for the overall cohort was 26.7 additional years at 20 years of age and 27.9 additional years at 35 years of age. Increased baseline CD4 cell count correlated positively with increased life expectancy. Older age groups showed similar trends.

"Ugandan patients receiving cART can expect an almost normal life expectancy, although there is considerable variability between subgroups of patients," the authors write.

Abstract
Full Text
Editorial

Copyright © 2011 HealthDay. All rights reserved.


Previous: Bed-Sharing With Children Not Linked to Cognitive Outcomes Next: Screening for Lynch Syndrome Beneficial at Acceptable Cost

Reader comments on this article are listed below. Review our comments policy.


Submit your opinion:

Name:

Email:

Location:

URL:

Remember my personal information

Notify me of follow-up comments?

advertisement.gif (61x7 -- 0 bytes)
 

Are you a Doctor, Pharmacist, PA or a Nurse?

Join the Doctors Lounge online medical community

  • Editorial activities: Publish, peer review, edit online articles.

Doctors Lounge Membership Application

 
     

 advertisement.gif (61x7 -- 0 bytes)

 

 

Useful Sites
MediLexicon
  Tools & Services: Follow DoctorsLounge on Twitter Follow us on Twitter | RSS News | Newsletter | Contact us
Copyright © 2001-2014
Doctors Lounge.
All rights reserved.

Medical Reference:
Diseases | Symptoms
Drugs | Labs | Procedures
Software | Tutorials

Advertising
Links | Humor
Forum Archive
CME | Conferences

Privacy Statement
Terms & Conditions
Editorial Board
About us | Email

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.